gsk2618960
Showing 1 - 1 of 1
Autoimmune Diseases Trial in Cambridge (GSK2618960, Placebo)
Completed
- Autoimmune Diseases
- GSK2618960
- Placebo
-
Cambridge, United KingdomGSK Investigational Site
May 5, 2017